Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 30

1.

Foreword by the Guest Editors of the new section of the IJC, "Migration and cardiovascular disease".

De Backer GG, Maggioni AP.

Int J Cardiol. 2018 Mar 1;254:353-355. doi: 10.1016/j.ijcard.2017.12.017. Epub 2017 Dec 14. No abstract available.

PMID:
29254880
2.

Prevention of cardiovascular disease in the working population at high cardiovascular risk.

De Backer GG.

Eur J Prev Cardiol. 2017 Sep;24(14):1541-1543. doi: 10.1177/2047487317719613. Epub 2017 Jul 11. No abstract available.

PMID:
28696145
3.

Food supplements with red yeast rice: More regulations are needed.

De Backer GG.

Eur J Prev Cardiol. 2017 Sep;24(13):1429-1430. doi: 10.1177/2047487317716500. Epub 2017 Jun 15. No abstract available.

PMID:
28617172
4.

New risk markers for cardiovascular prevention.

De Backer GG.

Curr Atheroscler Rep. 2014 Aug;16(8):427. doi: 10.1007/s11883-014-0427-z. Review.

PMID:
24881768
5.

Family history of cardiovascular disease and offspring echocardiographic left ventricular structure and function: the Asklepios Study.

Van daele CM, De Meyer T, De Buyzere ML, Gillebert TC, Denil SL, Bekaert S, Chirinos JA, De Backer GG, De Bacquer D, Rietzschel ER; Asklepios Investigators.

J Am Soc Echocardiogr. 2013 Nov;26(11):1290-1297.e2. doi: 10.1016/j.echo.2013.07.024. Epub 2013 Aug 28.

PMID:
23993692
6.

Addition of a novel, protective family history category allows better profiling of cardiovascular risk and atherosclerotic burden in the general population. The Asklepios Study.

Van daele CM, De Meyer T, De Buyzere ML, Gillebert TC, Denil SL, Bekaert S, Chirinos JA, Segers P, De Backer GG, De Bacquer D, Rietzschel ER; Asklepios Investigators.

PLoS One. 2013 May 2;8(5):e63185. doi: 10.1371/journal.pone.0063185. Print 2013.

7.

No shorter telomeres in subjects with a family history of cardiovascular disease in the Asklepios study.

De Meyer T, Van Daele CM, De Buyzere ML, Denil S, De Bacquer D, Segers P, Cooman L, De Backer GG, Gillebert TC, Bekaert S, Rietzschel ER; Asklepios Study investigators.

Arterioscler Thromb Vasc Biol. 2012 Dec;32(12):3076-81. doi: 10.1161/ATVBAHA.112.300341. Epub 2012 Oct 18.

8.

Common genetic variation in the 3'-BCL11B gene desert is associated with carotid-femoral pulse wave velocity and excess cardiovascular disease risk: the AortaGen Consortium.

Mitchell GF, Verwoert GC, Tarasov KV, Isaacs A, Smith AV, Yasmin, Rietzschel ER, Tanaka T, Liu Y, Parsa A, Najjar SS, O'Shaughnessy KM, Sigurdsson S, De Buyzere ML, Larson MG, Sie MP, Andrews JS, Post WS, Mattace-Raso FU, McEniery CM, Eiriksdottir G, Segers P, Vasan RS, van Rijn MJ, Howard TD, McArdle PF, Dehghan A, Jewell ES, Newhouse SJ, Bekaert S, Hamburg NM, Newman AB, Hofman A, Scuteri A, De Bacquer D, Ikram MA, Psaty BM, Fuchsberger C, Olden M, Wain LV, Elliott P, Smith NL, Felix JF, Erdmann J, Vita JA, Sutton-Tyrrell K, Sijbrands EJ, Sanna S, Launer LJ, De Meyer T, Johnson AD, Schut AF, Herrington DM, Rivadeneira F, Uda M, Wilkinson IB, Aspelund T, Gillebert TC, Van Bortel L, Benjamin EJ, Oostra BA, Ding J, Gibson Q, Uitterlinden AG, Abecasis GR, Cockcroft JR, Gudnason V, De Backer GG, Ferrucci L, Harris TB, Shuldiner AR, van Duijn CM, Levy D, Lakatta EG, Witteman JC.

Circ Cardiovasc Genet. 2012 Feb 1;5(1):81-90. doi: 10.1161/CIRCGENETICS.111.959817. Epub 2011 Nov 8.

9.

Genome-wide association study identifies six new loci influencing pulse pressure and mean arterial pressure.

Wain LV, Verwoert GC, O'Reilly PF, Shi G, Johnson T, Johnson AD, Bochud M, Rice KM, Henneman P, Smith AV, Ehret GB, Amin N, Larson MG, Mooser V, Hadley D, Dörr M, Bis JC, Aspelund T, Esko T, Janssens AC, Zhao JH, Heath S, Laan M, Fu J, Pistis G, Luan J, Arora P, Lucas G, Pirastu N, Pichler I, Jackson AU, Webster RJ, Zhang F, Peden JF, Schmidt H, Tanaka T, Campbell H, Igl W, Milaneschi Y, Hottenga JJ, Vitart V, Chasman DI, Trompet S, Bragg-Gresham JL, Alizadeh BZ, Chambers JC, Guo X, Lehtimäki T, Kühnel B, Lopez LM, Polašek O, Boban M, Nelson CP, Morrison AC, Pihur V, Ganesh SK, Hofman A, Kundu S, Mattace-Raso FU, Rivadeneira F, Sijbrands EJ, Uitterlinden AG, Hwang SJ, Vasan RS, Wang TJ, Bergmann S, Vollenweider P, Waeber G, Laitinen J, Pouta A, Zitting P, McArdle WL, Kroemer HK, Völker U, Völzke H, Glazer NL, Taylor KD, Harris TB, Alavere H, Haller T, Keis A, Tammesoo ML, Aulchenko Y, Barroso I, Khaw KT, Galan P, Hercberg S, Lathrop M, Eyheramendy S, Org E, Sõber S, Lu X, Nolte IM, Penninx BW, Corre T, Masciullo C, Sala C, Groop L, Voight BF, Melander O, O'Donnell CJ, Salomaa V, d'Adamo AP, Fabretto A, Faletra F, Ulivi S, Del Greco F, Facheris M, Collins FS, Bergman RN, Beilby JP, Hung J, Musk AW, Mangino M, Shin SY, Soranzo N, Watkins H, Goel A, Hamsten A, Gider P, Loitfelder M, Zeginigg M, Hernandez D, Najjar SS, Navarro P, Wild SH, Corsi AM, Singleton A, de Geus EJ, Willemsen G, Parker AN, Rose LM, Buckley B, Stott D, Orru M, Uda M; LifeLines Cohort Study, van der Klauw MM, Zhang W, Li X, Scott J, Chen YD, Burke GL, Kähönen M, Viikari J, Döring A, Meitinger T, Davies G, Starr JM, Emilsson V, Plump A, Lindeman JH, Hoen PA, König IR; EchoGen consortium, Felix JF, Clarke R, Hopewell JC, Ongen H, Breteler M, Debette S, Destefano AL, Fornage M; AortaGen Consortium, Mitchell GF; CHARGE Consortium Heart Failure Working Group, Smith NL; KidneyGen consortium, Holm H, Stefansson K, Thorleifsson G, Thorsteinsdottir U; CKDGen consortium; Cardiogenics consortium; CardioGram, Samani NJ, Preuss M, Rudan I, Hayward C, Deary IJ, Wichmann HE, Raitakari OT, Palmas W, Kooner JS, Stolk RP, Jukema JW, Wright AF, Boomsma DI, Bandinelli S, Gyllensten UB, Wilson JF, Ferrucci L, Schmidt R, Farrall M, Spector TD, Palmer LJ, Tuomilehto J, Pfeufer A, Gasparini P, Siscovick D, Altshuler D, Loos RJ, Toniolo D, Snieder H, Gieger C, Meneton P, Wareham NJ, Oostra BA, Metspalu A, Launer L, Rettig R, Strachan DP, Beckmann JS, Witteman JC, Erdmann J, van Dijk KW, Boerwinkle E, Boehnke M, Ridker PM, Jarvelin MR, Chakravarti A, Abecasis GR, Gudnason V, Newton-Cheh C, Levy D, Munroe PB, Psaty BM, Caulfield MJ, Rao DC, Tobin MD, Elliott P, van Duijn CM.

Nat Genet. 2011 Sep 11;43(10):1005-11. doi: 10.1038/ng.922.

10.

Long-term results from statin trials: answers but more unresolved questions.

De Backer GG.

Eur Heart J. 2011 Oct;32(20):2479-80. doi: 10.1093/eurheartj/ehr303. Epub 2011 Aug 28. No abstract available.

PMID:
21873709
11.

Noninvasive assessment of central and peripheral arterial pressure (waveforms): implications of calibration methods.

Mahieu D, Kips J, Rietzschel ER, De Buyzere ML, Verbeke F, Gillebert TC, De Backer GG, De Bacquer D, Verdonck P, Van Bortel LM, Segers P; Asklepios investigators.

J Hypertens. 2010 Feb;28(2):300-5. doi: 10.1097/HJH.0b013e3283340a1a.

PMID:
19901847
12.

Systemic telomere length and preclinical atherosclerosis: the Asklepios Study.

De Meyer T, Rietzschel ER, De Buyzere ML, Langlois MR, De Bacquer D, Segers P, Van Damme P, De Backer GG, Van Oostveldt P, Van Criekinge W, Gillebert TC, Bekaert S; Asklepios Study Investigators.

Eur Heart J. 2009 Dec;30(24):3074-81. doi: 10.1093/eurheartj/ehp324.

PMID:
19687155
13.

Lower red blood cell counts in middle-aged subjects with shorter peripheral blood leukocyte telomere length.

De Meyer T, De Buyzere ML, Langlois M, Rietzschel ER, Cassiman P, De Bacquer D, Van Oostveldt P, De Backer GG, Gillebert TC, Van Criekinge W, Bekaert S; Asklepios Investigators.

Aging Cell. 2008 Oct;7(5):700-5. doi: 10.1111/j.1474-9726.2008.00419.x. Epub 2008 Jul 28.

14.

Oxidized low-density lipoprotein cholesterol is associated with decreases in cardiac function independent of vascular alterations.

Rietzschel ER, Langlois M, De Buyzere ML, Segers P, De Bacquer D, Bekaert S, Cooman L, Van Oostveldt P, Verdonck P, De Backer GG, Gillebert TC; Asklepios Investigators.

Hypertension. 2008 Sep;52(3):535-41. doi: 10.1161/HYPERTENSIONAHA.108.114439. Epub 2008 Jul 28.

15.

Femoral plaques confound the association of circulating oxidized low-density lipoprotein with carotid atherosclerosis in a general population aged 35 to 55 years: the Asklepios Study.

Langlois MR, Rietzschel ER, De Buyzere ML, De Bacquer D, Bekaert S, Blaton V, De Backer GG, Gillebert TC; Asklepios Investigators.

Arterioscler Thromb Vasc Biol. 2008 Aug;28(8):1563-8. doi: 10.1161/ATVBAHA.108.167346. Epub 2008 May 29.

16.

Paternal age at birth is an important determinant of offspring telomere length.

De Meyer T, Rietzschel ER, De Buyzere ML, De Bacquer D, Van Criekinge W, De Backer GG, Gillebert TC, Van Oostveldt P, Bekaert S; Asklepios investigators.

Hum Mol Genet. 2007 Dec 15;16(24):3097-102. Epub 2007 Sep 19.

PMID:
17881651
17.

Telomere length and cardiovascular risk factors in a middle-aged population free of overt cardiovascular disease.

Bekaert S, De Meyer T, Rietzschel ER, De Buyzere ML, De Bacquer D, Langlois M, Segers P, Cooman L, Van Damme P, Cassiman P, Van Criekinge W, Verdonck P, De Backer GG, Gillebert TC, Van Oostveldt P; Asklepios investigators.

Aging Cell. 2007 Oct;6(5):639-47.

18.

Be physically active: the best buy in promoting heart health.

De Backer GG, De Bacquer D.

Eur Heart J. 2004 Dec;25(24):2183-4. No abstract available.

PMID:
15589633
19.

Issues for cardiovascular disease risk factor development in Europe.

De Backer GG, Maes L, Van de Mieroop E.

Prev Med. 1999 Dec;29(6 Pt 2):S96-101. Review.

PMID:
10641825
20.

Long-term outcome of surgical revascularization in ischemic nephropathy: normalization of average decline in renal function.

van Rooden CJ, van Bockel JH, De Backer GG, Hermans J, Chang PC.

J Vasc Surg. 1999 Jun;29(6):1037-49.

Supplemental Content

Loading ...
Support Center